Doctor profile · Federal record
Dr. Jennifer Richardson, M.D.
Rheumatology Physician (CMS: Rheumatology) · Columbus, OH
- NPI 1275511057
- Accepts Medicare
- MIPS 85.6 / 100 · 2023
- 28 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
170 Taylor Station RD Ste 300
Columbus, OH 432134491
(614) 486-5200
fax (614) 486-9665 - Additional location
-
1211 Dublin RD
Columbus, OH 432151091 - Mailing address
-
1211 Dublin RD
Columbus, OH 432151091
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- August 26, 2025
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Ohio #35076943
- Medicaid
- OH #2460797
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1275511057. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
55,592
Distinct HCPCS
10
Medicare allowed
$1,050,620
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 20,560 | 17 | $6 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 14,544 | 34 | $13 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 8,074 | 60 | $32 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 6,625 | 35 | $42 | |
J0897 |
Injection, denosumab, 1 mg | 2,880 | 33 | $23 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 428 | 66 | $1 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 367 | 153 | $121 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 355 | 222 | $122 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 281 | 188 | $8 | |
80053 |
Blood test, comprehensive group of blood chemicals | 262 | 173 | $10 |
In context: peer comparison
Among 18 peers in Columbus Rheumatology Physician, average services per provider: 1,015. This provider delivers 55× the peer median.Open Payments
Industry payments received
All-time total
$491
Transactions
28
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 18 | $283.03 | |
| Pfizer INC. | 4 | $93.22 | |
| GlaxoSmithKline, LLC. | 4 | $76.63 | |
| Organon LLC | 1 | $23.09 | |
| Amgen INC. | 1 | $15.04 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,143
Patients
635
Total drug cost
$1,454,973
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 389 | 133 | $21,639 |
| Hydroxychloroquine Sulfate | Generic | 344 | 117 | $34,842 |
| Tramadol Hcl | Generic | 289 | 62 | $2,927 |
| Leflunomide | Generic | 210 | 71 | $21,833 |
| Prednisone | Generic | 210 | 96 | $2,281 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 107 | 24 | $4,231 |
| Gabapentin | Generic | 102 | 39 | $1,811 |
| Celecoxib | Generic | 89 | 39 | $7,624 |
| Alendronate Sodium | Generic | 86 | 29 | $593 |
| Meloxicam | Generic | 75 | 25 | $659 |
Frequently asked questions
What is Dr. Jennifer Richardson's medical specialty?
Dr. Jennifer Richardson practices Rheumatology Physician in Columbus, OH.
Where does Dr. Jennifer Richardson practice?
Dr. Jennifer Richardson practices at 170 Taylor Station RD Ste 300, Columbus, OH 432134491. Office phone: 6144865200.
What is Dr. Jennifer Richardson's NPI?
Dr. Jennifer Richardson's National Provider Identifier (NPI) is 1275511057, issued by NPPES.
Does Dr. Jennifer Richardson accept Medicare assignment?
Yes. Dr. Jennifer Richardson accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jennifer Richardson commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.